Lymphocyte chromatin study
A 2004 case series in elderly subjects reported activated ribosomal genes and decondensed chromatin in lymphocytes after short peptide administration. Reported in the cited paper.
SourceResearch Use Only. Products listed are not for human or animal consumption. Statements have not been evaluated by the FDA.View full disclaimers →
The directory
83 listed
Newsletter · Quarterly
Get notified about new lab results, price drops and supplier coupons before everyone else.
We respect your privacy. No spam.
Epitalon is a synthetic tetrapeptide based on epithalamin from the pineal gland, studied for telomerase activation and cellular ageing. Nearly all of its evidence traces to the originating Russian research group, with no randomised controlled trials.
Vendor listings
Show prices as
81 listings · Epitalon
In stock10mgseen 6d ago
In stock10mgseen 4d ago
In stock10mgseen 4d ago
In stock10mgseen 6d ago
In stock10mgseen 4d ago
In stock10mgseen 7d ago
In stock10mgseen 4d ago
In stock10mgseen 5d ago
In stock10mgseen 5d ago
In stock10mgseen 6d ago
In stock10mgseen 6d ago
In stock10mgseen 7d ago
In stock10mgseen 4d ago
In stock10mgseen 4d ago
In stock10mgseen 5d ago
In stock10mgseen 3d ago
In stock10mgseen 3d ago
In stock10mgseen 4d ago
In stock10mgseen 3d ago
In stock10mgseen 3d ago
Overview
Epitalon is a synthetic tetrapeptide based on epithalamin from the pineal gland, studied for telomerase activation and cellular ageing. Nearly all of its evidence traces to the originating Russian research group, with no randomised controlled trials.
What the research reports
Outcomes described across the published Epitalon literature and ongoing study. Read each as research context rather than a promised personal result.
Telomerase activation research
In vitro work reported telomere elongation in human fibroblasts, which is the central mechanistic claim made for this peptide. Reported in research settings.
Geroprotective animal data
Animal studies describe geroprotective effects, including preserved retinal structure and function in ageing rats over extended periods. Reported in research settings.
Chromatin and gene activity
A 2004 case series in elderly subjects reported activated ribosomal genes and decondensed chromatin in circulating lymphocytes. Reported in research settings.
Chromosome stability work
Small case series reported reduced chromosomal instability in patients with hypertrophic cardiomyopathy and after tuberculosis treatment. Reported in research settings.
Antioxidant mechanism study
Proposed antioxidant and neuroprotective mechanisms appear across the literature, though human efficacy remains unestablished. Reported in research settings.
Dosage and protocol
Standard protocols use 5 to 10 mg once daily for 10 to 20 days, repeated every 4 to 6 months rather than run continuously. Figures describe study protocols, not a personal regimen.
Clinical evidence
The published Epitalon record, labeled by strength so you can see what is settled and what is still emerging.
A 2004 case series in elderly subjects reported activated ribosomal genes and decondensed chromatin in lymphocytes after short peptide administration. Reported in the cited paper.
SourceA 2003 animal study reported that retinal morphology and function were preserved roughly twice as long as in untreated control animals. Reported in the cited paper.
SourceA 2008 case series of eight subjects reported that epithalon reduced heavy metal induced chromosome fragility in cultured cells. As reported in the cited publication.
SourceInteractions
Questions